Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126885311 | 12688531 | 1 | I | 20160822 | 20160822 | 20160825 | 20160825 | EXP | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-54901BP | BOEHRINGER INGELHEIM | 82.49 | YR | F | Y | 0.00000 | 20160826 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126885311 | 12688531 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 300 MG | 22512 | 150 | MG | CAPSULE | BID | ||||||
| 126885311 | 12688531 | 2 | SS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | 22512 | ||||||||||||
| 126885311 | 12688531 | 3 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Unknown | 0 | |||||||||||
| 126885311 | 12688531 | 4 | C | MULTAQ | DRONEDARONE | 1 | Unknown | 0 | |||||||||||
| 126885311 | 12688531 | 5 | C | CARDIZEM CD | DILTIAZEM HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 126885311 | 12688531 | 6 | C | ALTACE | RAMIPRIL | 1 | Unknown | 0 | |||||||||||
| 126885311 | 12688531 | 7 | C | FOLIC ACID. | FOLIC ACID | 1 | Unknown | 0 | |||||||||||
| 126885311 | 12688531 | 8 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG | 0 | 81 | MG | TABLET | QD | ||||||
| 126885311 | 12688531 | 9 | C | LASIX | FUROSEMIDE | 1 | Unknown | 0 | |||||||||||
| 126885311 | 12688531 | 10 | C | calcium with vitamin D | CALCIUMVITAMIN D | 1 | Unknown | 0 | |||||||||||
| 126885311 | 12688531 | 11 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126885311 | 12688531 | 1 | Cerebrovascular accident prophylaxis |
| 126885311 | 12688531 | 2 | Atrial fibrillation |
| 126885311 | 12688531 | 3 | Hyperlipidaemia |
| 126885311 | 12688531 | 4 | Atrial fibrillation |
| 126885311 | 12688531 | 5 | Hypertension |
| 126885311 | 12688531 | 6 | Hypertension |
| 126885311 | 12688531 | 7 | Product used for unknown indication |
| 126885311 | 12688531 | 8 | Product used for unknown indication |
| 126885311 | 12688531 | 9 | Product used for unknown indication |
| 126885311 | 12688531 | 10 | Product used for unknown indication |
| 126885311 | 12688531 | 11 | Gastrooesophageal reflux disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126885311 | 12688531 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126885311 | 12688531 | Haemorrhage intracranial | |
| 126885311 | 12688531 | Hypertension |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126885311 | 12688531 | 1 | 20160822 | 0 |